165 related articles for article (PubMed ID: 10516045)
1. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.
Blanchard S; Astier-Gin T; Tallet B; Moynet D; Londos-Gagliardi D; Guillemain B
J Virol; 1999 Nov; 73(11):9369-76. PubMed ID: 10516045
[TBL] [Abstract][Full Text] [Related]
2. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
[TBL] [Abstract][Full Text] [Related]
3. Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I.
Blanchard S; Astier-Gin T; Moynet D; Edouard E; Guillemain B
Virology; 1998 May; 245(1):90-8. PubMed ID: 9614870
[TBL] [Abstract][Full Text] [Related]
4. Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.
Mirsaliotis A; Nurkiyanova K; Lamb D; Woof JM; Brighty DW
J Virol; 2007 Jun; 81(11):6019-31. PubMed ID: 17376912
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
[TBL] [Abstract][Full Text] [Related]
6. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
7. Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation?
Pique C; Tursz T; Dokhelar MC
EMBO J; 1990 Dec; 9(13):4243-8. PubMed ID: 2124968
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.
Cook RF; Berger SL; Rushlow KE; McManus JM; Cook SJ; Harrold S; Raabe ML; Montelaro RC; Issel CJ
J Virol; 1995 Mar; 69(3):1493-9. PubMed ID: 7853482
[TBL] [Abstract][Full Text] [Related]
9. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
[TBL] [Abstract][Full Text] [Related]
10. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
11. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus.
Kim FJ; Seiliez I; Denesvre C; Lavillette D; Cosset FL; Sitbon M
J Biol Chem; 2000 Aug; 275(31):23417-20. PubMed ID: 10851227
[TBL] [Abstract][Full Text] [Related]
12. Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice.
Grange MP; Armand MA; Audoly G; Thollot D; Desgranges C
DNA Cell Biol; 1997 Dec; 16(12):1439-48. PubMed ID: 9428792
[TBL] [Abstract][Full Text] [Related]
13. Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.
Kothe DL; Decker JM; Li Y; Weng Z; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Salazar-Gonzalez JF; Moldoveanu Z; Mestecky J; Gao F; Haynes BF; Shaw GM; Muldoon M; Korber BT; Hahn BH
Virology; 2007 Mar; 360(1):218-34. PubMed ID: 17097711
[TBL] [Abstract][Full Text] [Related]
14. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands.
Benson J; Tschachler E; Gessain A; Yanagihara R; Gallo RC; Franchini G
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):91-6. PubMed ID: 8179967
[TBL] [Abstract][Full Text] [Related]
15. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
[TBL] [Abstract][Full Text] [Related]
16. Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.
Delamarre L; Pique C; Pham D; Tursz T; Dokhélar MC
J Virol; 1994 Jun; 68(6):3544-9. PubMed ID: 8189493
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
Jassal SR; Pöhler RG; Brighty DW
J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
[TBL] [Abstract][Full Text] [Related]
18. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
Palker TJ; Riggs ER; Spragion DE; Muir AJ; Scearce RM; Randall RR; McAdams MW; McKnight A; Clapham PR; Weiss RA
J Virol; 1992 Oct; 66(10):5879-89. PubMed ID: 1326649
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis of envelope glycoproteins from diverse geographical isolates of bovine leukemia virus identifies highly conserved peptide motifs.
Pluta A; Albritton LM; Rola-Łuszczak M; Kuźmak J
Retrovirology; 2018 Jan; 15(1):2. PubMed ID: 29310678
[TBL] [Abstract][Full Text] [Related]
20. The HTLV-I envelope glycoproteins: structure and functions.
Delamarre L; Rosenberg AR; Pique C; Pham D; Callebaut I; Dokhélar MC
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S85-91. PubMed ID: 8797709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
